Compare XLO & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XLO | ABLV |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 39.0M |
| IPO Year | 2021 | N/A |
| Metric | XLO | ABLV |
|---|---|---|
| Price | $0.57 | $0.80 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 572.5K | 13.2K |
| Earning Date | 03-10-2026 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $31,804,000.00 | ★ $114,319,869.00 |
| Revenue This Year | $626.78 | N/A |
| Revenue Next Year | $79.08 | N/A |
| P/E Ratio | ★ N/A | $17.33 |
| Revenue Growth | ★ 588.40 | N/A |
| 52 Week Low | $0.50 | $0.59 |
| 52 Week High | $1.70 | $1.77 |
| Indicator | XLO | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 59.02 |
| Support Level | $0.50 | $0.74 |
| Resistance Level | $0.61 | $0.87 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 55.80 | 65.00 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.